Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.

British journal of cancer - 1 Dec 1995

Sliutz G, Tempfer C, Winkler S, Kohlberger P, Reinthaller A, Kainz C

Abstract excerpt

The surface glycoprotein CD44 is widely distributed in different tissues. In contrast to healthy tissue, tumour samples show a more complex pattern of CD44 expression, indicating a loss of splice control. Beside cell-surface expression, the measurement of soluble CD44 in serum of cancer patients could be useful in early diagnosis and assessment of disease status. We evaluated the surface expression of CD44...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Alternative Splicing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Epitopes

Share to Genetic Variation

Share to Immunohistochemistry

Share to Ovarian Neoplasms

Share to Reference Values

Source

Open in PubMed Open full text

Identifiers

PMID: 8519665
DOI: 10.1038/bjc.1995.535
PMCID: PMC2034075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.PMID 8519665Read ↗

Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.Semantic proximity Read ↗

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer PrognosisSemantic proximity Read ↗

Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.Semantic proximity Read ↗

Current status of CD44 variant isoforms as cancer diagnostic markers.Semantic proximity Read ↗

Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products.Semantic proximity Read ↗

Expression of cadherins and CD44 isoforms in ovarian endometrial cysts.Semantic proximity Read ↗

[Occurrence of CD44 and its isoforms under orthological and pathological conditions].Semantic proximity Read ↗

Expression of CD44 splice variants in human skin and epidermal tumours.Semantic proximity Read ↗

Expression and modulation of CD44 variant isoforms in humansSemantic proximity Read ↗

Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeysSemantic proximity Read ↗

Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.Semantic proximity Read ↗

Soluble CD44 splice variants in metastasizing human breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.